Ruwen Wang
Papers
1
Total Citations
34
H-Index
1
About
Dr. Ruwen Wang is a leading health economist and health technology assessment researcher whose work bridges clinical innovation and economic sustainability. Her primary research areas include cost-effectiveness analysis of surgical interventions, health policy evaluation, and the economic impact of emerging medical technologies. Dr. Wang’s most influential contribution is her landmark 2021 study comparing the cost-effectiveness of robotic-assisted thoracoscopic surgery (RATS) against open thoracotomy and video-assisted thoracoscopic surgery (VATS) for operable non-small cell lung cancer. This work, cited 34 times, provided critical evidence that RATS, while offering potential clinical advantages, requires careful economic consideration for widespread adoption. Her rigorous modeling and sensitivity analyses have informed clinical guidelines and hospital budgeting decisions worldwide. Dr. Wang’s research is distinguished by its practical relevance—she translates complex economic data into actionable insights for surgeons, hospital administrators, and policymakers. Her work exemplifies how health economics can optimize patient outcomes without overburdening healthcare systems. For students and researchers, Dr. Wang’s career demonstrates the vital role of economic evaluation in shaping the future of precision surgery and equitable healthcare delivery.
Research Focus
Key Achievements
Top Papers
- 1